Innovative Preclinical Candidates Based on Butyrylcholinesterase Inhibitors for the Palliative Treatment of Alzheimer’s Disease (NW26-08-00163)
Basic information
Investigator: RNDr. Tomáš Petrásek, Ph.D.
Main recipient: University Hospital Hradec Králové
Co-recipient: National Institute of Mental Health (NIMH),
Research period: 01/01/2026 – 12/31/2029
Total budget: 15,183,000 CZK
NIMH budget: 7,439,000 CZK
Supported by: AZV (Czech Health Research Council)
Annotation